awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28072087-242371D9-8AF8-4547-9E86-17A72A0FC183
Q28072087-242371D9-8AF8-4547-9E86-17A72A0FC183
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28072087-242371D9-8AF8-4547-9E86-17A72A0FC183
Administration of Traditional Chinese Blood Circulation Activating Drugs for Microvascular Complications in Patients with Type 2 Diabetes Mellitus
P2860
Q28072087-242371D9-8AF8-4547-9E86-17A72A0FC183
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28072087-242371D9-8AF8-4547-9E86-17A72A0FC183
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3ebb94e0c6f6ce5db089a40e1bad43f7a6be3dc0
P2860
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema